Class Action Cases

Join the case to recover your losses. Click "Join this Class Action" above.

Attorneys

Bioventus Inc.

Join Class Action »

According to the Complaint, the Company made false and misleading statements to the market. Bioventus was suffering from a liquidity crisis. The Company could not sustain its rebate practices. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company’s public statements throughout the IPO and class period were false and materially misleading throughout the class period. When the market learned the truth about Bioventus, investors suffered damages.

Press Release

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Bioventus Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, January 23, 2023 — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Bioventus Inc. (“Bioventus” or “the Company”) (NASDAQ: BVS) for violations of the federal securities laws.

Investors who purchased the Company’s shares pursuant and/or traceable to the Company’s initial public offering conducted on February 11, 2021 (the “IPO”) and/or between February 11, 2021 and November 21, 2022, both dates inclusive (the “Class Period”), are encouraged to contact the firm before March 13, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Bioventus was suffering from a liquidity crisis. The Company could not sustain its rebate practices. The Company failed to maintain appropriate controls over financial reporting. Based on these facts, the Company’s public statements throughout the IPO and class period were false and materially misleading. When the market learned the truth about Bioventus, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

 

SOURCE:

The Schall Law Firm

Cases

  • Drop files here or
    Accepted file types: xls, xlsx, doc, pdf, jpg, jpeg, Max. file size: 32 MB, Max. files: 5.
      You may redact your account numbers from your uploaded documents. The Schall Law Firm is committed to protecting the privacy of confidential information. Your documents will be securely held in AWS S3 and will only be used as proof of your transactions in connection with this matter.
    • Purchases
      MM slash DD slash YYYY
      If fractional shares, please round to the nearest whole number.
    • Sales
      MM slash DD slash YYYY
    • By submitting your information, you acknowledge that this form does not create an attorney-client relationship between yourself and The Schall Law Firm. Any information you submit will be maintained as confidential. The Schall Law Firm, in its sole discretion, will contact you if it requires further information from you.